Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Levy

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Internal Medicine|September 4, 2012
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literatureMoshe Vardi, Shany Blum, Andrew P Levy
The New England Journal of Medicine|April 15, 2011
Cholesterol efflux capacity and atherosclerosisRabea Asleh, Andrew P Levy, Shany Blum
Clinical Nutrition (Edinburgh, Scotland)|May 26, 2009
Antioxidants in the prevention of atherosclerosis: the importance of proper patient selectionYishai Levy, Shany Blum, Andrew P Levy
The Journal of Biological Chemistry|February 9, 2002
A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuRIlana Goldberg-Cohen, Henry Furneauxb, Andrew P Levy
Pharmacological Research|April 3, 2012
Haptoglobin genotype and its role in determining heme-iron mediated vascular diseaseHagit Goldenstein, Nina S Levy, Andrew P Levy
Molecules (Basel, Switzerland)|November 11, 2010
Antioxidant vitamins and their use in preventing cardiovascular diseaseDan Farbstein, Adena Kozak-Blickstein, Andrew P Levy
Journal of Lipid Research|March 19, 2013
Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selectionMoshe Vardi, Nina S Levy, Andrew P Levy
Acta Histochemica|February 15, 2005
New horizons for VEGF. Is there a role for nuclear localization?Flavio Lejbkowicz, Ilana Goldberg-Cohen, Andrew P Levy
Atherosclerosis|September 25, 2009
The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaqueShiri Kalet-Litman, Pedro R Moreno, Andrew P Levy
Pharmacogenomics|August 7, 2008
Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular diseaseShany Blum, Uzi Milman, Chen Shapira, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Internal Medicine|September 4, 2012
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literatureMoshe Vardi, Shany Blum, Andrew P Levy
The New England Journal of Medicine|April 15, 2011
Cholesterol efflux capacity and atherosclerosisRabea Asleh, Andrew P Levy, Shany Blum
Clinical Nutrition (Edinburgh, Scotland)|May 26, 2009
Antioxidants in the prevention of atherosclerosis: the importance of proper patient selectionYishai Levy, Shany Blum, Andrew P Levy
The Journal of Biological Chemistry|February 9, 2002
A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuRIlana Goldberg-Cohen, Henry Furneauxb, Andrew P Levy
Pharmacological Research|April 3, 2012
Haptoglobin genotype and its role in determining heme-iron mediated vascular diseaseHagit Goldenstein, Nina S Levy, Andrew P Levy
Molecules (Basel, Switzerland)|November 11, 2010
Antioxidant vitamins and their use in preventing cardiovascular diseaseDan Farbstein, Adena Kozak-Blickstein, Andrew P Levy
Journal of Lipid Research|March 19, 2013
Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selectionMoshe Vardi, Nina S Levy, Andrew P Levy
Acta Histochemica|February 15, 2005
New horizons for VEGF. Is there a role for nuclear localization?Flavio Lejbkowicz, Ilana Goldberg-Cohen, Andrew P Levy
Atherosclerosis|September 25, 2009
The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaqueShiri Kalet-Litman, Pedro R Moreno, Andrew P Levy
Pharmacogenomics|August 7, 2008
Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular diseaseShany Blum, Uzi Milman, Chen Shapira, et al.
Pageof 14